Goodwin
Kenny Walker-Durrant
- Deals
- 2
- Latest
- Jul 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Mitch Bloom 1 deal together
- Adam Dilluvio 1 deal together
- Markus Käpplinger 1 deal together
- Wei Xu 1 deal together
- Sarah Solomon 1 deal together
- Graham Defries 1 deal together
- Kingsley L. Taft 1 deal together
- Yifeng Yuan 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jul 2026 | Myricx Bio | – | Novartis | Acquisition | Legal adviser to Myricx Bio (target) | Announced | 1,100.0 | Biotech+1 | Novartis acquisition of Myricx Bio |
| Apr 2026 | Tubulis | EQT Life Sciences (LSP 7 fund) | Gilead Sciences | Acquisition | Legal adviser to Tubulis (target) | Announced | 3,150.0 | Biotech+2 | Gilead Sciences acquisition of Tubulis |
Deals where Kenny Walker-Durrant is named on the firm's deal team, by the firm or the press.